<html>
  <head>
    <title></title>
    <!-- Licensed to: The Ideal Connection
         Document created using EDGARfilings PROfile 6.3.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div style="text-align: center;">
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;">
    <div><br>
    </div>
    UNITED STATES</div>
  <div style="text-align: center;">SECURITIES AND EXCHANGE COMMISSION</div>
  <div style="text-align: center;">WASHINGTON, DC 20549</div>
  <div><br>
  </div>
  <div style="text-align: center;">FORM 8-K</div>
  <div><br>
  </div>
  <div style="text-align: center;">CURRENT REPORT PURSUANT</div>
  <div style="text-align: center;">TO SECTION 13 OR 15(D) OF THE</div>
  <div style="text-align: center;">SECURITIES EXCHANGE ACT OF 1934</div>
  <div><br>
  </div>
  <div style="text-align: center;">Date of Report (Date of earliest event reported): December 17, 2019</div>
  <div style="text-align: center;"> <br>
  </div>
  <div style="text-align: center; font-weight: bold;"><u>QRONS INC.</u></div>
  <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
  <div><br>
  </div>
  <div style="text-align: center;"><u>Wyoming</u></div>
  <div style="text-align: center;">(State or other jurisdiction of incorporation)</div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" id="z31977b3a67f94ae4aa5cbbc606bf592c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: center;">000-55800</div>
        </td>
        <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: center;">81-3623646</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">
          <div style="text-align: center;">&#160;(Commission File Number)</div>
        </td>
        <td style="width: 50%; vertical-align: top;">
          <div style="text-align: center;">&#160;(IRS Employer Identification No.)</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="margin: 0px; font-family: 'Times New Roman',Times,serif; text-align: center;"><u>50 Battery Place, #7T, New York, New York 10280</u> </div>
  <div style="font-family: 'Times New Roman',Times,serif; text-align: center;">(Address of principal executive offices) (Zip Code)</div>
  <div style="font-family: 'Times New Roman',Times,serif; text-align: center;"> <br>
  </div>
  <div style="font-family: 'Times New Roman',Times,serif; text-align: center;"><u>(212)-945-2080</u></div>
  <div style="text-align: center;">(Registrant's telephone number, including area code)</div>
  <div><br>
  </div>
  <div style="text-align: center;">___________________________________________</div>
  <div style="text-align: center;">&#160;(Former Name or Former Address, if Changed Since Last Report)</div>
  <div><br>
  </div>
  <div>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
    provisions (see General Instruction A.2. below):</div>
  <div><br>
  </div>
  <div style="text-align: justify;">|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
  <div><br>
  </div>
  <div style="text-align: justify;">|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
  <div><br>
  </div>
  <div style="text-align: justify;">|_|&#160; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
  <div><br>
  </div>
  <div style="text-align: justify;">|_|&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
  <div><br>
  </div>
  <div style="background-color: #FFFFFF;">
    <div>Securities registered pursuant to Section 12(b) of the Act: None</div>
    <div><br>
    </div>
  </div>
  <table cellspacing="0" cellpadding="0" id="zbc1e10514cbb4b01a9e836aa0dc46d00" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 33.59%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Title of each class</div>
        </td>
        <td style="width: 1.4%; vertical-align: bottom;">
          <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
        </td>
        <td style="width: 19.1%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Trading</div>
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Symbol(s)</div>
        </td>
        <td style="width: 1.4%; vertical-align: bottom;">
          <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
        </td>
        <td style="width: 44.51%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Name of each exchange</div>
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">on which registered</div>
        </td>
      </tr>
      <tr>
        <td style="width: 33.59%; vertical-align: top;">
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">None</div>
        </td>
        <td style="width: 1.4%; vertical-align: bottom;">
          <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
        </td>
        <td style="width: 19.1%; vertical-align: top;">
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">N/A</div>
        </td>
        <td style="width: 1.4%; vertical-align: bottom;">
          <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
        </td>
        <td style="width: 44.51%; vertical-align: top;">
          <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">N/A</div>
        </td>
      </tr>

  </table>
  <div style="background-color: #FFFFFF;">
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">1</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or
    Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>
  <div style="text-indent: 36pt; margin-left: 252pt; margin-bottom: 5.25pt; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Emerging
      growth company </font><font style="font-size: 10pt;">[X]</font></div>
  <div>If an emerging growth company, indicate by check mark if the registrant has elected
      not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&#160; ]</div>
  <div style="margin-bottom: 5.25pt;"><br>
  </div>
  <div><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
    <div id="DSPFPageBreak" style="page-break-after:always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; font-weight: bold;">Section 3 - Securities and Trading Markets</div>
  <div style="text-align: justify; font-weight: bold;">Item 3.02&#160; Unregistered Sales of Equity Securities</div>
  <div><br>
  </div>
  <div style="text-align: justify;">On December 17, 2019, Qrons Inc. (the &#8220;Company&#8221;) granted a five-year immediately exercisable option to purchase 325,000 shares of its common stock at an
    exercise price of $2.00 per share, to each of Jonah Meer, its Chief Executive Officer, and Ido Merfeld, its President, for services provided to the Company.</div>
  <div><br>
  </div>
  <div style="text-align: justify;">On December 17, 2019, the Company granted three-year options to purchase an aggregate of 100,000 shares of the Company&#8217;s common stock at an exercise price of
    $2.00 per share, to Liat Hammer, the Company&#8217;s Director of Research for services provided to the Company. 33,334 of such shares subject to the option are immediately exercisable and expire on December 17, 2022, 33,333 shares vest on December 17, 2020
    and expire on December 17, 2023 and 33,333 shares vest on December 17, 2021 and expire on December 17, 2024.</div>
  <div><br>
  </div>
  <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">The above issuances did not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe is exempt from the
    registration requirements of the Securities Act of 1933, as amended, by virtue of Section 4(2) thereof.</div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
    by the undersigned hereunto duly authorized.</div>
  <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
  <div style="text-align: justify; text-indent: 36pt;">
    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

        <tr>
          <td valign="top" style="width: 50%;">&#160;</td>
          <td valign="top" style="width: 38%;" colspan="2"><strong>QRONS, INC. <br>
            </strong></td>
          <td valign="top" style="width: 12%;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 50%;">&#160;</td>
          <td valign="top" style="width: 3%;">&#160;</td>
          <td valign="top" style="width: 35%;">&#160;</td>
          <td valign="top" style="width: 12%;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">Date: December 20, 2019<br>
            </div>
          </td>
          <td valign="top" style="width: 3%; padding-bottom: 2px;">
            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">By: </div>
          </td>
          <td valign="top" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">/s/Jonah Meer<br>
          </td>
          <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 50%;">&#160;</td>
          <td valign="top" style="width: 3%;">&#160;</td>
          <td valign="bottom" align="left" style="width: 35%;">Name: Jonah Meer <br>
          </td>
          <td valign="top" style="width: 12%;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 50%;">&#160;</td>
          <td valign="top" style="width: 3%;">&#160;</td>
          <td valign="top" style="width: 35%;">Title: Chief Executive Officer <br>
          </td>
          <td valign="top" style="width: 12%;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 50%;">&#160;</td>
          <td valign="top" style="width: 3%;">&#160;</td>
          <td valign="top" style="width: 35%;">&#160;</td>
          <td valign="top" style="width: 12%;">&#160;</td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <br>
  <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "form8k.htm", "description": "8-K", "secsgml_size_bytes": 13240}]
{"company-data": {"conformed-name": "Qrons Inc.", "cik": "0001689084", "assigned-sic": "2836", "irs-number": "813623646", "state-of-incorporation": "WY", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-55800", "film-number": "191298148"}, "business-address": {"street1": "50 BATTERY PLACE, #7T", "city": "NEW YORK", "state": "NY", "zip": "10280", "phone": "212-945-2080"}, "mail-address": {"street1": "50 BATTERY PLACE, #7T", "city": "NEW YORK", "state": "NY", "zip": "10280"}, "former-company": {"former-conformed-name": "BIOLABMART INC.", "date-changed": "20161102"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 17, 2019
QRONS INC.
(Exact name of registrant as specified in its charter)
Wyoming
(State or other jurisdiction of incorporation)
000-55800
81-3623646
(Commission File Number)
(IRS Employer Identification No.)
50 Battery Place, #7T, New York, New York 10280
(Address of principal executive offices) (Zip Code)
(212)-945-2080
(Registrant's telephone number, including area code)
___________________________________________
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
    provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|_|  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|_|  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
None
N/A
N/A
1
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
    Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
      growth company
[X]
If an emerging growth company, indicate by check mark if the registrant has elected
      not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]
2
Section 3 - Securities and Trading Markets
Item 3.02  Unregistered Sales of Equity Securities
On December 17, 2019, Qrons Inc. (the "Company") granted a five-year immediately exercisable option to purchase 325,000 shares of its common stock at an
    exercise price of $2.00 per share, to each of Jonah Meer, its Chief Executive Officer, and Ido Merfeld, its President, for services provided to the Company.
On December 17, 2019, the Company granted three-year options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of
    $2.00 per share, to Liat Hammer, the Company's Director of Research for services provided to the Company. 33,334 of such shares subject to the option are immediately exercisable and expire on December 17, 2022, 33,333 shares vest on December 17, 2020
    and expire on December 17, 2023 and 33,333 shares vest on December 17, 2021 and expire on December 17, 2024.
The above issuances did not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe is exempt from the
    registration requirements of the Securities Act of 1933, as amended, by virtue of Section 4(2) thereof.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
    by the undersigned hereunto duly authorized.
QRONS, INC.
Date: December 20, 2019
By:
/s/Jonah Meer
Name: Jonah Meer
Title: Chief Executive Officer
3